Serum Institute gets go-ahead to conduct Phase II/III clinical trials of Novavax Covid vaccine
New Delhi: The Subject Expert Committee (SEC) of India's central drug regulatory authority has given a go-ahead to the Serum Institute...
New Delhi: The Subject Expert Committee (SEC) of India's central drug regulatory authority has given a go-ahead to the Serum Institute...
Sydney: US-based biotechnology company Novavax has started enrolling participants in Australia for a clinical trial of its coronavirus vaccine candidate, NVX-CoV2373....